The contingent value right (CVR) offered by BMS as a sweetener for the $74 billion takeover of Celgene in 2019 is defunct, as one of the three drugs – CAR-T therapy liso-cel for lymphoma ...

Shareholders in Celgene accepted a “contingent value right” (CVR) to sweeten the $74 billion merger with BMS in November. Liso-cel is a CAR-T (chimeric antigen receptor T-cell ...

Mark J. Alberts, MD, has disclosed the following relevant financial relationships: Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee ...

Here are 10 of the best French bakeries in Brisbane where you'll find baguettes, croissants, loaves and pastries with that authentic Parisian taste: Crust & Co has been reincarnated as Oh My Bread, a ...